Clonazepam Tablets/Odt Suppliers & Bulk Manufacturers
Available Forms: Tablets/ODT
Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Reference Brands: US: Klonopin®, Clonazepam ODT; EU: Rivotril®, Clonex®, Clonotril®, Clonarex®
Category:
Antipsychotropic Drugs
Clonazepam, a benzodiazepine, enhances GABA-A receptor activity, increasing chloride influx to stabilize neuronal membranes and reduce excitability. It is primarily used to treat seizure disorders, including absence and myoclonic seizures, and panic disorder. Orally disintegrating tablets (ODT) offer rapid onset, beneficial for acute symptom control.
Clonazepam Tablets/ODT is available in Tablets/ODT
and strengths such as 0.25 mg, 0.5 mg, 1 mg, 2 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clonazepam Tablets/ODT is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clonazepam Tablets/ODT can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clonazepam tablets and orally disintegrating tablets (ODT) are approved by the U.S. FDA for the treatment of seizure disorders and panic disorder. The products must comply with cGMP, include boxed warnings on CNS depression, and be dispensed with Medication Guides. In the European Union, Clonazepam is authorized through national procedures or mutual recognition for epilepsy and related conditions. EU regulations require Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). Manufacturing sites must be GMP-certified. For B2B sourcing and dossier-ready formulations, explore more Clonazepam forms at Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing